A quick prediction tool for unfavourable outcome in COVID-19 inpatients:development and internal validation
As COVID-19 pandemic continues to escalate, hospitals around the world confront with the need to attend an increasing number of patients. Therefore, we read with much interest the recent study published in the Journal of Infection by Galloway JB et al., reinforcing the importance of stratifying patients to ease their management and their incorporation to potential clinical trials [1]. For this purpose, these authors developed a valuable and complex risk score based on twelve parameters, including, among others, age, gender, diabetes mellitus, hypertension, and chronic lung disease.
Source: Journal of Infection - Category: Infectious Diseases Authors: Sonsoles Salto-Alejandre, Cristina Roca-Oporto, Guillermo Mart ín-Gutiérrez, María Dolores Avilés, Carmen Gómez-González, María Dolores Navarro-Amuedo, Julia Praena-Segovia, José Molina, María Paniagua-García, Horacio García-Delgado, Antonio Do Source Type: research
More News: Clinical Trials | COVID-19 | Diabetes | Diabetes Mellitus | Endocrinology | Hospitals | Hypertension | Infectious Diseases | Pandemics | Study